Pages that link to "Q33362763"

The following pages link to Tetramolecular immune complexes are more efficient than IVIg to prevent antibody-dependent in vitro and in vivo phagocytosis of blood cells (Q33362763):

Displaying 24 items.

• Immune complexes as therapy for autoimmunity (Q24558642) (← links)
• Reversal of immune thrombocytopenia in mice by cross-linking human immunoglobulin G with a high-affinity monoclonal antibody (Q33372342) (← links)
• Absence of cytokine modulation following therapeutic infusion of intravenous immunoglobulin or anti-red blood cell antibodies in a mouse model of immune thrombocytopenic purpura (Q33374445) (← links)
• Picogram doses of lipopolysaccharide exacerbate antibody-mediated thrombocytopenia and reduce the therapeutic efficacy of intravenous immunoglobulin in mice (Q33376821) (← links)
• Immune regulation by B cells and antibodies a view towards the clinic. (Q33381036) (← links)
• Immunoglobulin G dimers and immune complexes are dispensable for the therapeutic efficacy of intravenous immune globulin in murine immune thrombocytopenia (Q33401630) (← links)
• Fully recombinant IgG2a Fc multimers (stradomers) effectively treat collagen-induced arthritis and prevent idiopathic thrombocytopenic purpura in mice (Q33402880) (← links)
• CD44 antibody-mediated amelioration of murine immune thrombocytopenia (ITP): mouse background determines the effect of FcγRIIb genetic disruption (Q33419269) (← links)
• A monoclonal antibody with anti-D-like activity in murine immune thrombocytopenia requires Fc domain function for immune thrombocytopenia ameliorative effects (Q33420988) (← links)
• Passively administered pooled human immunoglobulins exert IL-10 dependent anti-inflammatory effects that protect against fatal HSV encephalitis (Q33926907) (← links)
• Recombinant IgG2a Fc (M045) multimers effectively suppress experimental autoimmune myasthenia gravis. (Q35899107) (← links)
• Co-opting endogenous immunoglobulin for the regulation of inflammation and osteoclastogenesis in humans and mice (Q36687271) (← links)
• Optimization of an enrichment process for circulating tumor cells from the blood of head and neck cancer patients through depletion of normal cells (Q37531679) (← links)
• Neutralization of mitogenic lectins by intravenous immunoglobulin (IVIg) prevents T cell activation: does IVIg really have a direct effect on T cells? (Q39447037) (← links)
• Anti-CD20 Antibody with Multimerized Fc Domains: A Novel Strategy To Deplete B Cells and Augment Treatment of Autoimmune Disease. (Q40180170) (← links)
• Divergent intracellular sorting of Fc{gamma}RIIA and Fc{gamma}RIIB2. (Q42117406) (← links)
• Highly parallel characterization of IgG Fc binding interactions. (Q42909129) (← links)
• Multivalent Fcγ-receptor engagement by a hexameric Fc-fusion protein triggers Fcγ-receptor internalisation and modulation of Fcγ-receptor functions. (Q47148202) (← links)
• Unraveling the IVIG mystique (Q48304490) (← links)
• Beneficial effect of a multimerized immunoglobulin Fc in an animal model of inflammatory neuropathy (experimental autoimmune neuritis). (Q50895051) (← links)
• Elucidating the interplay between IgG-Fc valency and FcγR activation for the design of immune complex inhibitors (Q51321746) (← links)
• Engineered hexavalent Fc proteins with enhanced Fc-gamma receptor avidity provide insights into immune-complex interactions (Q57074754) (← links)
• Variability of the inhibition by total immunoglobulin of in vitro autoantibody-mediated erythrophagocytosis by mouse macrophages (Q79771625) (← links)
• A fully recombinant human IgG1 Fc multimer (GL-2045) inhibits complement-mediated cytotoxicity and induces iC3b (Q89777975) (← links)